0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

HIV/AIDS Early Treatment Controversy Cues New Advice but Questions Remain

Marsha F. Goldsmith
JAMA. 1993;270(3):295-296. doi:10.1001/jama.1993.03510030015003.
Text Size: A A A
Published online

ABSTRACT

IN THE ATMOSPHERE of confusion about how best to treat people infected with the human immunodeficiency virus (HIV) that was engendered by reports at the Ninth International Conference on AIDS, held last month in Berlin, Germany, a panel convened by a US government agency met 2 weeks later in Bethesda, Md, to consider all the evidence and suggest a new, state-of-the-art, therapeutic approach.

At what point physicians should reach into their scant antiretroviral armamentarium for one of the three drugs approved to intervene in the natural history of infection with the virus was the issue addressed by a group of nongovernmental experts on the acquired immunodeficiency syndrome (AIDS).

The panel's 18 members convened for 3 days at the National Institute of Allergy and Infectious Diseases and issued somewhat cautious and necessarily complicated new recommendations— the first since 1990—for treating persons with the disease. While there is no regulatory authority behind

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();